Makers Laboratories Ltd

Makers Laboratories Ltd

₹ 130 3.37%
12 Apr 4:01 p.m.
About

Incorporated in 1984, Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. [1]

Key Points

Product Portfolio
The Co’s product portfolio covers a wide range of General Health Therapeutic segments. Its top formulation brands are Duramol (Paracetamol), Artemak-AB (a-ß Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). [1]

  • Market Cap 77.0 Cr.
  • Current Price 130
  • High / Low 157 / 94.0
  • Stock P/E
  • Book Value 111
  • Dividend Yield 0.00 %
  • ROCE 1.08 %
  • ROE -3.43 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Stock is trading at 1.17 times its book value

Cons

  • Company has low interest coverage ratio.
  • Earnings include an other income of Rs.1.23 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
14.88 30.96 36.29 33.57 29.47 27.29 25.45 26.50 19.88 29.45 25.01 25.06 26.51
14.40 26.33 30.53 27.66 24.93 25.25 25.44 24.87 20.06 27.66 25.23 24.86 26.31
Operating Profit 0.48 4.63 5.76 5.91 4.54 2.04 0.01 1.63 -0.18 1.79 -0.22 0.20 0.20
OPM % 3.23% 14.95% 15.87% 17.61% 15.41% 7.48% 0.04% 6.15% -0.91% 6.08% -0.88% 0.80% 0.75%
0.31 0.34 0.59 0.61 1.37 0.62 1.01 0.88 0.27 0.12 0.33 0.41 0.37
Interest 0.41 0.58 0.43 0.50 0.39 0.41 0.39 1.07 0.42 0.25 0.41 0.49 0.53
Depreciation 1.16 1.43 1.00 1.03 1.01 0.99 0.89 1.03 1.19 1.13 1.11 1.13 1.16
Profit before tax -0.78 2.96 4.92 4.99 4.51 1.26 -0.26 0.41 -1.52 0.53 -1.41 -1.01 -1.12
Tax % -42.31% 49.66% 24.19% 28.46% 22.84% 26.98% -219.23% 82.93% -17.11% 33.96% -18.44% -10.89% 4.46%
-1.10 1.49 3.73 3.57 3.49 0.93 -0.83 0.07 -1.78 0.35 -1.66 -1.13 -1.06
EPS in Rs -2.56 0.37 3.08 2.95 3.44 -1.03 -2.75 -1.08 -3.75 -0.47 -3.56 -2.27 -2.61
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 TTM
69 127 101 106
60 108 98 104
Operating Profit 8 19 3 2
OPM % 12% 15% 3% 2%
1 3 2 1
Interest 2 2 2 2
Depreciation 5 4 4 5
Profit before tax 3 16 -1 -3
Tax % 50% 25% -161%
1 12 -2 -4
EPS in Rs -0.56 8.44 -8.05 -8.91
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -120%
Stock Price CAGR
10 Years: 21%
5 Years: 19%
3 Years: -20%
1 Year: 17%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5 5 6 6
Reserves 49 55 63 60
21 23 17 15
62 62 66 73
Total Liabilities 136 144 152 154
71 68 85 83
CWIP 0 9 0 2
Investments 2 0 0 0
63 66 67 68
Total Assets 136 144 152 154

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
0 18 -9
0 -22 1
0 0 6
Net Cash Flow 0 -3 -2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
Debtor Days 88 39 72
Inventory Days 344 166 281
Days Payable 182 38 91
Cash Conversion Cycle 250 167 262
Working Capital Days 159 104 140
ROCE % 15% 1%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
58.37% 58.37% 58.37% 58.37% 58.37% 61.27% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
41.63% 41.63% 41.63% 41.63% 41.63% 38.72% 38.73% 38.73% 38.72% 38.73% 38.73% 38.74%
No. of Shareholders 3,9143,9433,9374,0754,6674,7534,8394,6214,4834,4024,2834,179

Documents